Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
I Peace, Inc. Begins Clinical-Grade Induced Pluripotent Stem Cells Custom Manufacturing Service 2020-05-16 01:00
Happiness Biotech Announced Innovative Cultivation Technology of Lucidum 2020-05-13 20:00
China Biologic Products to Report First Quarter 2020 Financial Results 2020-05-12 20:30
BGI's Real-time Fluorescent RT-PCR Kit for Detecting 2019-nCoV eligible for WHO Emergency Use Listing 2020-05-12 02:00
Singlera Genomics Meets with FDA for Rapid Colon Cancer Assay and Has a Clear Path Forward 2020-05-12 01:39
Neurophth Therapeutics Announces Presentations at ASGCT and ARVO Annual Meetings 2020-05-11 20:00
Hummingbird Bioscience Closes US$25 Million Investment With Series B Extension 2020-05-11 08:00
HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance 2020-05-08 23:00
Bridge Biotherapeutics Announces the IND Clearance of BBT-176, an EGFR TKI for NSCLC, in South Korea 2020-05-08 07:30
VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update 2020-05-08 04:10
Happiness Biotech Announced the Sales of Epidemic Prevention Products Have Exceeded RMB45 million 2020-05-07 20:00
VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update 2020-05-05 20:30
WuXi AppTec Reports Solid First-Quarter 2020 Results 2020-04-29 17:30
QBiotics commercialises first tigilanol tiglate pharmaceutical product with launch of STELFONTA® 2020-04-28 14:43
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma 2020-04-27 18:00
Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies 2020-04-23 20:30
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody) 2020-04-23 08:00
Samsung Biologics Earnings to Beat Consensus Again, Continues to Sign New Projects with Enhanced Virtual Support 2020-04-22 19:00
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001 2020-04-20 23:00
Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma 2020-04-20 08:00
1 123 124 125 126 127 222